Kevin C. Oboyle, Director at GenMark Diagnostics, Inc. (GNMK), sold 272 shares at $11.64 ($3K) on 2014-06-11, disclosed to the SEC on 2014-06-13.
Scheduled sale ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GNMK | SELL | 2019-08-19 | $225K | — | Filing → |
| SIEN | BUY | 2019-06-11 | $50K | — | Filing → |
| NVRO | BUY | 2019-06-07 | $101K | — | Filing → |